Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
Could This Be the End of PEPFAR? • February 6, 2025
Short email from a longtime colleague, working in Africa at a PEPFAR site: Without USAID, PEPFAR is essentially dead. I got chills reading this. PEPFAR, the abbreviation for the President’s Emergency Plan for AIDS Relief, started in 2003 under the direction of President George W. Bush. To say it’s been a resounding success undersells the impact of the […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.The views and opinions expressed in these blogs are not necessarily those of NEJM Journal Watch or NEJM Group.
NEJM Journal Watch — Recent Infectious Diseases Articles- Epstein-Barr Virus as a Cause of Cancer in Recipients of Kidney Transplantation
- Management of Drug-Susceptible and Drug-Resistant Tuberculosis — Updated Guidelines
- Durlobactam May Be Active in Treating Mycobacterium abscessus
- ME/CFS Incidence Is Higher Following COVID-19
- Antivirals for Nonsevere Influenza: Benefits Remain Uncertain
- NEJM Journal Watch — Recent General Medicine Articles